Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Price

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Neurobiology of Pain (Cambridge, Mass.)|April 11, 2025
Humanized Na<sub>V</sub>1.8 rats overcome cross-species potency shifts in developing novel Na<sub>V</sub>1.8 inhibitorsDillon S McDevitt, Joshua D Vardigan, Xiaoping Zhou, et al.
Journal of Medicinal Chemistry|October 13, 2006
Macrocyclic inhibitors of beta-secretase: functional activity in an animal modelShawn J Stachel, Craig A Coburn, Sethu Sankaranarayanan, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2010
Rapid P1 SAR of brain penetrant tertiary carbinamine derived BACE inhibitorsHong Zhu, Mary B Young, Philippe G Nantermet, et al.
Journal of Medicinal Chemistry|June 23, 2007
Discovery of isonicotinamide derived beta-secretase inhibitors: in vivo reduction of beta-amyloidMatthew G Stanton, Shaun R Stauffer, Alison R Gregro, et al.
The Journal of Biological Chemistry|March 2, 2005
Compounds that bind APP and inhibit Abeta processing in vitro suggest a novel approach to Alzheimer disease therapeuticsAmy S Espeseth, Min Xu, Qian Huang, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitorsStacey R Lindsley, Keith P Moore, Hemaka A Rajapakse, et al.
Journal of Medicinal Chemistry|September 25, 2008
Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretaseJames C Barrow, Shaun R Stauffer, Kenneth E Rittle, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2008
First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primatesSethu Sankaranarayanan, Marie A Holahan, Dennis Colussi, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Neurobiology of Pain (Cambridge, Mass.)|April 11, 2025
Humanized Na<sub>V</sub>1.8 rats overcome cross-species potency shifts in developing novel Na<sub>V</sub>1.8 inhibitorsDillon S McDevitt, Joshua D Vardigan, Xiaoping Zhou, et al.
Journal of Medicinal Chemistry|October 13, 2006
Macrocyclic inhibitors of beta-secretase: functional activity in an animal modelShawn J Stachel, Craig A Coburn, Sethu Sankaranarayanan, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2010
Rapid P1 SAR of brain penetrant tertiary carbinamine derived BACE inhibitorsHong Zhu, Mary B Young, Philippe G Nantermet, et al.
Journal of Medicinal Chemistry|June 23, 2007
Discovery of isonicotinamide derived beta-secretase inhibitors: in vivo reduction of beta-amyloidMatthew G Stanton, Shaun R Stauffer, Alison R Gregro, et al.
The Journal of Biological Chemistry|March 2, 2005
Compounds that bind APP and inhibit Abeta processing in vitro suggest a novel approach to Alzheimer disease therapeuticsAmy S Espeseth, Min Xu, Qian Huang, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitorsStacey R Lindsley, Keith P Moore, Hemaka A Rajapakse, et al.
Journal of Medicinal Chemistry|September 25, 2008
Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretaseJames C Barrow, Shaun R Stauffer, Kenneth E Rittle, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2008
First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primatesSethu Sankaranarayanan, Marie A Holahan, Dennis Colussi, et al.
Pageof 2